A biotechnology company, pursuing commercial opportunities in: out-licensing its non-coding patents globally; expanding genetic service-testing business in the Asia-Pacific Region; & supporting research projects in which it is already involved.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Note the 3 month timeframe on my speculative swing trades.
My 11th call on Genetic Technologies, 4 down, 7 up? Lost count. Usually, best to wait for a low float, low volume equity to spike and then point it back down if you're "into" learning about "mood swings" here on CAPS. Sometimes up works when one gets a reliable pattern....until it doesn't.
Swings from $3.20 to $4.00 are "normal". Could spike higher, could drop. With a 30:1 ADR, however, means that it broke the "dime" in Aussieland..
I believe commerical productization will be slow and limited. Salesforce is expensive. No general opinion really, however on valuation, it's a "trading" stock until it makes up its mind.